Yakult Honsha Co (TSE:2267) Risk Assessment

View and export this data going back to 1980. Start your Free Trial

What is Yakult Honsha Co Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Yakult Honsha Co is: Low Risk: Strong fundamentals, worth long-term holding.

Competitive Comparison of Yakult Honsha Co's Risk Assessment

For the Beverages - Non-Alcoholic subindustry, Yakult Honsha Co's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Yakult Honsha Co's Risk Assessment Distribution in the Beverages - Non-Alcoholic Industry

For the Beverages - Non-Alcoholic industry and Consumer Defensive sector, Yakult Honsha Co's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Yakult Honsha Co's Risk Assessment falls into.

Yakult Honsha Co (TSE:2267) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Yakult Honsha Co Risk Assessment Related Terms

Thank you for viewing the detailed overview of Yakult Honsha Co's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Yakult Honsha Co (TSE:2267) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Beverages - Non-Alcoholic » Yakult Honsha Co Ltd (TSE:2267) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

YKLTY:USA YKH:Germany

Address

1-19 Higashi Shimbashi 1-chome, Minato-ku, Tokyo, JPN, 105-0021

Website

http://www.yakult.co.jp

Yakult is a pioneer in probiotics, which launched the probiotic drinks Yakult in 1935 after Minoru Shirota's discovery of Lactobacillus casei strain Shirota, a strain of lactic acid bacteria proved to be able to live in intestines, in 1930. It operates in 40 countries across four continents selling mainly the Yakult probiotic drinks. Apart from the retail outlets, the home delivery channel, served by a team of 83,000 Yakult Ladies globally, contributes about 45% of its probiotic drink volume. Overseas markets comprise 40% of group sales and profits. Yakult has built a meaningful presence in populated emerging markets including China, Indonesia, Mexico, and Brazil. It plans to step up expansion in the U.S. It also operates a pharmaceutical business with an emphasis on oncology drugs.

Yakult Honsha Co (TSE:2267) Headlines

No Headlines